HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emma Bolderson Selected Research

chloropyramine

10/2020SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer.
11/2016SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emma Bolderson Research Topics

Disease

11Genomic Instability
01/2021 - 05/2008
9Neoplasms (Cancer)
01/2021 - 06/2006
6Ataxia Telangiectasia (Louis Bar Syndrome)
09/2015 - 12/2004
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 10/2020
3Lung Neoplasms (Lung Cancer)
09/2021 - 01/2020
3Progeria (Hutchinson Gilford Syndrome)
01/2021 - 12/2014
2Adenocarcinoma
09/2021 - 10/2020
2Breast Neoplasms (Breast Cancer)
11/2016 - 05/2014
2Hypersensitivity (Allergy)
04/2010 - 08/2009
2Chromosomal Instability (Chromosome Stability)
04/2010 - 08/2009
1Xeroderma Pigmentosum (Kaposi's Disease)
10/2021
1Premature Aging
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Chromosome Aberrations (Chromosome Abnormalities)
06/2014
1Familial Breast Cancer
05/2014
1Triple Negative Breast Neoplasms
05/2014
1Genetic Translocation (Chromosomal Translocation)
01/2014

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
10/2021 - 10/2009
12DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2004
5Phosphotransferases (Kinase)IBA
09/2015 - 12/2004
4PlatinumIBA
09/2021 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2021 - 05/2014
3ChromatinIBA
01/2021 - 08/2012
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2020
31,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
09/2015 - 04/2010
3DNA-Binding Proteins (DNA Binding Protein)IBA
04/2013 - 05/2008
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 - 10/2009
2Indicators and Reagents (Reagents)IBA
10/2020 - 08/2009
2Messenger RNA (mRNA)IBA
10/2020 - 01/2016
2chloropyramineIBA
10/2020 - 11/2016
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 - 10/2009
1Tyrosine Kinase InhibitorsIBA
09/2021
1ErbB Receptors (EGF Receptor)IBA
09/2021
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2021
1Carboplatin (JM8)FDA LinkGeneric
01/2021
1Cytotoxins (Cytolysins)IBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Small Interfering RNA (siRNA)IBA
11/2016
1NucleophosminIBA
01/2016
1Alanine (L-Alanine)FDA Link
12/2014
1Threonine (L-Threonine)FDA Link
12/2014
1CamptothecinIBA
06/2014
1Pharmaceutical PreparationsIBA
05/2014
1Co-Repressor ProteinsIBA
08/2012
1HeterochromatinIBA
08/2012
1human EXO1 proteinIBA
04/2010
1Antineoplastic Agents (Antineoplastics)IBA
10/2009
1Carrier Proteins (Binding Protein)IBA
10/2009
1dimemorfan (AT 17)IBA
06/2006
1Ataxia Telangiectasia Mutated ProteinsIBA
12/2004

Therapy/Procedure

10Therapeutics
09/2021 - 10/2009
5Drug Therapy (Chemotherapy)
09/2021 - 10/2009
3Immunotherapy
01/2021 - 01/2020